Olympus Corporation (OCPNF)
USD 15.5
(0.0%)
USD 15.5
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 589.83 Billion JPY | 11.09% |
| 2023 | 562.69 Billion JPY | 18.22% |
| 2022 | 475.99 Billion JPY | 11.22% |
| 2021 | 427.98 Billion JPY | -3.73% |
| 2020 | 444.56 Billion JPY | -7.32% |
| 2019 | 479.69 Billion JPY | -0.29% |
| 2018 | 481.11 Billion JPY | 7.49% |
| 2017 | 447.56 Billion JPY | -16.26% |
| 2016 | 534.48 Billion JPY | 9.11% |
| 2015 | 489.85 Billion JPY | 11.21% |
| 2014 | 440.45 Billion JPY | 16.46% |
| 2013 | 378.19 Billion JPY | -1.46% |
| 2012 | 383.8 Billion JPY | -1.0% |
| 2011 | 387.68 Billion JPY | -5.04% |
| 2010 | 408.24 Billion JPY | -11.49% |
| 2009 | 461.22 Billion JPY | -9.47% |
| 2008 | 509.47 Billion JPY | 13.15% |
| 2007 | 450.28 Billion JPY | 25.7% |
| 2006 | 358.22 Billion JPY | 20.59% |
| 2005 | 297.07 Billion JPY | -0.5% |
| 2004 | 298.56 Billion JPY | 10.25% |
| 2003 | 270.81 Billion JPY | 23.22% |
| 2002 | 219.77 Billion JPY | 12.56% |
| 2001 | 195.26 Billion JPY | -54.45% |
| 2000 | 428.64 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 589.83 Billion JPY | 4.82% |
| 2024 Q1 | 137.22 Billion JPY | -15.88% |
| 2024 Q3 | 162.99 Billion JPY | 7.79% |
| 2024 Q2 | 151.21 Billion JPY | 10.19% |
| 2024 Q4 | 173.69 Billion JPY | 6.56% |
| 2023 Q2 | 151.8 Billion JPY | 10.64% |
| 2023 Q1 | 137.2 Billion JPY | -14.17% |
| 2023 FY | 562.69 Billion JPY | 18.22% |
| 2023 Q4 | 163.12 Billion JPY | 4.43% |
| 2023 Q3 | 156.19 Billion JPY | 2.89% |
| 2022 Q1 | 123.31 Billion JPY | -9.35% |
| 2022 Q3 | 141.58 Billion JPY | -3.65% |
| 2022 Q4 | 159.85 Billion JPY | 12.91% |
| 2022 FY | 475.99 Billion JPY | 11.22% |
| 2022 Q2 | 146.94 Billion JPY | 19.16% |
| 2021 Q2 | 110.7 Billion JPY | 29.86% |
| 2021 Q1 | 85.25 Billion JPY | -28.13% |
| 2021 Q4 | 136.03 Billion JPY | 6.66% |
| 2021 FY | 427.98 Billion JPY | -3.73% |
| 2021 Q3 | 127.53 Billion JPY | 15.2% |
| 2020 Q2 | 130.29 Billion JPY | 11.64% |
| 2020 FY | 444.56 Billion JPY | -7.32% |
| 2020 Q3 | 124.81 Billion JPY | -4.21% |
| 2020 Q4 | 118.62 Billion JPY | -4.96% |
| 2020 Q1 | 116.71 Billion JPY | -11.02% |
| 2019 Q2 | 130.49 Billion JPY | 10.27% |
| 2019 Q1 | 118.34 Billion JPY | -13.97% |
| 2019 Q4 | 131.16 Billion JPY | 1.24% |
| 2019 FY | 479.69 Billion JPY | -0.29% |
| 2019 Q3 | 129.55 Billion JPY | -0.72% |
| 2018 Q3 | 131.15 Billion JPY | 1.78% |
| 2018 FY | 481.11 Billion JPY | 7.49% |
| 2018 Q1 | 112.88 Billion JPY | -17.94% |
| 2018 Q4 | 137.57 Billion JPY | 4.89% |
| 2018 Q2 | 128.86 Billion JPY | 14.15% |
| 2017 Q3 | 118.99 Billion JPY | 2.31% |
| 2017 Q2 | 116.3 Billion JPY | 4.52% |
| 2017 FY | 447.56 Billion JPY | -16.26% |
| 2017 Q1 | 111.27 Billion JPY | -21.33% |
| 2017 Q4 | 137.56 Billion JPY | 15.61% |
| 2016 FY | 534.48 Billion JPY | 9.11% |
| 2016 Q2 | 141.04 Billion JPY | 15.85% |
| 2016 Q1 | 121.74 Billion JPY | -12.68% |
| 2016 Q4 | 141.43 Billion JPY | 7.95% |
| 2016 Q3 | 131.02 Billion JPY | -7.1% |
| 2015 FY | 489.85 Billion JPY | 11.21% |
| 2015 Q2 | 119.02 Billion JPY | 11.88% |
| 2015 Q3 | 125.03 Billion JPY | 5.05% |
| 2015 Q1 | 106.37 Billion JPY | -13.61% |
| 2015 Q4 | 139.41 Billion JPY | 11.5% |
| 2014 Q2 | 110.77 Billion JPY | 17.73% |
| 2014 Q3 | 112.45 Billion JPY | 1.52% |
| 2014 Q4 | 123.13 Billion JPY | 9.5% |
| 2014 FY | 440.45 Billion JPY | 16.46% |
| 2014 Q1 | 94.09 Billion JPY | -8.92% |
| 2013 Q2 | 100.78 Billion JPY | 16.32% |
| 2013 Q4 | 103.31 Billion JPY | 18.13% |
| 2013 Q3 | 87.45 Billion JPY | -13.22% |
| 2013 Q1 | 86.64 Billion JPY | -13.6% |
| 2013 FY | 378.19 Billion JPY | -1.46% |
| 2012 Q2 | 99.7 Billion JPY | 10.99% |
| 2012 Q1 | 89.83 Billion JPY | -8.71% |
| 2012 Q3 | 93.99 Billion JPY | -5.73% |
| 2012 Q4 | 100.28 Billion JPY | 6.69% |
| 2012 FY | 383.8 Billion JPY | -1.0% |
| 2011 Q1 | 96.83 Billion JPY | -7.46% |
| 2011 Q2 | 98.42 Billion JPY | 1.64% |
| 2011 FY | 387.68 Billion JPY | -5.04% |
| 2011 Q4 | 98.4 Billion JPY | 4.77% |
| 2011 Q3 | 93.92 Billion JPY | -4.57% |
| 2010 Q1 | 95.8 Billion JPY | -4.32% |
| 2010 FY | 408.24 Billion JPY | -11.49% |
| 2010 Q3 | 100.79 Billion JPY | -5.81% |
| 2010 Q4 | 104.64 Billion JPY | 3.82% |
| 2010 Q2 | 107 Billion JPY | 11.7% |
| 2009 FY | 461.22 Billion JPY | -9.47% |
| 2009 Q4 | 100.13 Billion JPY | 2.25% |
| 2009 Q3 | 97.92 Billion JPY | -28.99% |
| 2009 Q2 | 137.9 Billion JPY | 10.09% |
| 2009 Q1 | 125.26 Billion JPY | 0.0% |
| 2008 FY | 509.47 Billion JPY | 13.15% |
| 2007 FY | 450.28 Billion JPY | 25.7% |
| 2006 FY | 358.22 Billion JPY | 20.59% |
| 2005 FY | 297.07 Billion JPY | -0.5% |
| 2004 FY | 298.56 Billion JPY | 10.25% |
| 2003 FY | 270.81 Billion JPY | 23.22% |
| 2002 FY | 219.77 Billion JPY | 12.56% |
| 2001 FY | 195.26 Billion JPY | -54.45% |
| 2000 FY | 428.64 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -34714017.475% |
| Ansell Limited | 624.8 Million USD | -94303.009% |
| Ansell Limited | 624.8 Million USD | -94303.009% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -517558.22% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -436733082.777% |
| Psykey, Inc. | 415.97 Thousand USD | -141794138.129% |
| ConvaTec Group Plc | 1.2 Billion USD | -48925.695% |
| ConvaTec Group Plc | 1.17 Billion USD | -50106.844% |
| Encision Inc. | 3.13 Million USD | -18808482.502% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -74284577.959% |
| LifePoint, Inc. | -71.35 Thousand USD | 826578759.716% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 450252008.397% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -112348471.429% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -97776904.177% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -98894808.127% |
| SmileDirectClub, Inc. | 275.84 Million USD | -213725.055% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | -65383.631% |
| SheerVision, Inc. | 2.17 Million USD | -27107191.711% |
| United Health Products, Inc. | -4857.00 USD | 12143916097.529% |
| Vasamed, Inc. | -69.38 Thousand USD | 850046217.484% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -220362819.044% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -1120242245.97% |